Post by Nomad Foods

“The key is understanding how to support consumers on this journey: at the shelf edge, online, and through the products we offer.”   The Nomad Foods Podcast is back, and in the latest episode, we sit down with Tom Wakeman, Insight Director at IGD (Institute of Grocery Distribution) to explore: 🔹 What GLP‑1 medications actually are  🔹 Misconceptions and myths surrounding their usage 🔹 How consumer behaviour is already shifting across categories 🔹 How retailers and manufacturers are responding 🔹 Why this isn’t a short‑term trend, but a long‑term structural shift 🔹 The opportunities for brands to support healthier lifestyles   Tom also shares how IGD is modelling GLP‑1’s impact over time and what manufacturers should prioritise as adoption accelerates both in the UK and further afield.   🎧 Listen to Episode 7 here: Spotify: https://lnkd.in/eRdwJMiH Apple Podcasts: https://lnkd.in/e-V8H7cE Amazon Music: https://lnkd.in/eExYzwEw